Lord, Abbett & Co’s Vericel Corp VCEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-121,278
Closed -$5.41M 588
2025
Q1
$5.41M Buy
121,278
+8,488
+8% +$457K 0.02% 453
2024
Q4
$6.19M Buy
+112,790
New +$5.71M 0.02% 449

Other funds holding VCEL

Lord, Abbett & Co's VCEL Position: Q2 2025 in Review

Lord, Abbett & Co sold out of Vericel Corp (VCEL) in Q2 2025, closing a stake of 121,278 shares — an estimated $5.41M sold.

Lord, Abbett & Co first reported a position in VCEL in Q4 2024 and held it in 2 quarters. The position peaked at $6.19M in Q4 2024. 273 funds tracked by Wall St. Rank hold VCEL as of Q2 2025.

  • Lord, Abbett & Co reported no remaining Vericel Corp position as of Q2 2025 after selling out during the quarter.
  • Lord, Abbett & Co sold 121,278 Vericel Corp shares in Q2 2025, an estimated $5.41M.
  • Lord, Abbett & Co first reported a position in Vericel Corp in Q4 2024 and held it in 2 quarters.
  • Lord, Abbett & Co's Vericel Corp position peaked at $6.19M in Q4 2024.
  • 273 funds tracked by Wall St. Rank held Vericel Corp as of Q2 2025.

Based on Lord, Abbett & Co's 13F filing for Q2 2025, filed 14 Aug 2025.